A clinical trial of lornoxicam mouth dissolving film for Management of pain after tooth extractio
Phase 2
- Conditions
- Health Condition 1: K029- Dental caries, unspecified
- Registration Number
- CTRI/2022/03/041167
- Lead Sponsor
- JSS Academy of Higher Education and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Adult patients of either sex of age group 20-50 years are selected for the study.
2.Subjects willing to be a part of the study and signed the written informed consent.
3.Patients who are diagnosed with grossly decayed tooth or periodontally compromised tooth with a poor prognosis which are indicated for extraction and extraction for orthodontic treatment.
4.Patient should be educated enough to understand and answer the protocol of VAS and OPS.
Exclusion Criteria
1.Subject allergic to any of the NSAIDs.
2.Pregnant or lactating women.
3.Subjects who are medically compromised (diabetes mellitus, cardiovascular diseases, hypertension, renal diseases, peptic ulcer)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of lornoxicam mouth dissolving film as a potent drug delivery system in management of post extraction pain.Timepoint: 1 month
- Secondary Outcome Measures
Name Time Method Effective management of post extraction painTimepoint: 1 month